Patent ID: 11903993
Assignee: MAIA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of administering bivalirudin to a patient in need thereof comprising intravenously administering to the patient a ready-to-use liquid composition consisting of about 5 mg/mL bivalirudin or a salt thereof, about 0.8 mg/mL sodium acetate trihydrate, about 100 mg/mL PEG 400, and water and optionally, glacial acetic acid and/or sodium hydroxide, wherein
the ready-to-use liquid composition is prepared by a method that comprises mixing bivalirudin or salt thereof, sodium acetate, PEG 400, and water and optionally glacial acetic acid and/or sodium hydroxide to form the ready-to-use liquid composition,
the composition has a pH of about 5.25, and
the composition has an osmolality of about 200 to about 600 mOsm/kg.